Animal Rights

The Commentary "Animal Rights (And Wrongs)" by Albert Kligman [The Scientist, Oct. 29, 1990, page 16] contains many misconceptions about animal testing that merit an educated response. In the last decades, we have found cures and treatments for tuberculosis, scarlet fever, influenza. pneumonia, diphtheria, whooping cough, measles, and smallpox. Most of the credit goes to improvement in nutrition, hygiene, and sanitation and better living conditions. With these advancements, we have been able

Written byMelissa Goldman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the last decades, we have found cures and treatments for tuberculosis, scarlet fever, influenza. pneumonia, diphtheria, whooping cough, measles, and smallpox.

Most of the credit goes to improvement in nutrition, hygiene, and sanitation and better living conditions. With these advancements, we have been able to effectively prevent these illnesses. Research on animals has not helped in this endeavor at all.

Many researchers are trading in their rodents for more sophisticate testing of cancer-fighting drugs. Tests on hundreds of different strains of human cancer cells growing in test tubes are much faster and less expensive than the tests on rodents.

Numerous advances have been made using non-animal methods, including:

The many advances that have been made using non-animal methods demonstrate that there are a myriad of alternatives available.

Avon, Revlon, and Estee Lauder all stopped testing on animals because they were shown alternatives that are faster, cheaper, and most important-more ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies